Press Releases

TORONTO, ONTARIO -- (MARKET WIRE) -- 02/10/12 -- CardioComm Solutions, Inc. (CardioComm Solutions) (TSX VENTURE: EKG) completed a recent interview with the Wall Street Reporter and an upcoming Ad in USA Today mark the beginning of a Marketing Communications Campaign in support of the company' entry into the Health Market with their recently announced Food and Drug Administration (FDA) clear HeartCheck" Pen Hand Held ECG targeted at consumers.

In his interview with the Wall Street Reporter Mr. Etienne Grima, CEO, discussed CardioComm Solution's current direction in the field of Telemedicine and provided insight into planned initiatives that the company will be launching over the next 24 months, initiatives building on proven and stable software products. The interview highlighted CardioComm Solutions as a software engineering company that is not dependent on others for software enhancements and innovations, a company emerging from three years of planning with an aim to close the gap in providing access for patients and consumers to qualified medical care.

Francois Paul Thibault, Canadian Designer and Sculpture of Yellow Knife, NWT, Canada said, "I believe CardioComm's technology will empower people with direct access to doctors and professional teams at breakneck wireless internet speeds. This will streamline our health system to where it should be and reach well beyond. CardioComm's new wireless propriety software and HeartCheckTM PEN technology will allow patients and individuals from all areas of the globe to save valuable time. What CardioComm will offer is the opportunity to save millions of dollars in medical travel services in regions like the NWT, the Yukon and Nunavut. Each year hundreds of people fly escorted to large centers for these types of test at an incredible cost to our Government and Health Care system. Investing in one of these PEN devices will save a world of uncertainties, alleviate sleepless nights and most importantly may save a multitude of lives. Finally the Star Trek Era is here."

CardioComm Solutions to Co Sponsor Publication for National Heart Health Month

In keeping with their commitment to patient education and awareness, CardioComm Solutions, Inc. will be co-sponsoring a major educational publication and campaign for National Heart Health Month. On February 23rd, 2012, Mediaplanet Publishing, Inc. will be releasing its 5th edition of "Cardiovascular Health" to be distributed in USA Today in key regional markets. The publication will stress the importance of open patient-doctor dialogue and will also address issues around Atrial Fibrillation. "We thought this would be a great opportunity to introduce the HeartCheckTM PEN to a consumer audience and discuss how innovative patient monitoring can help prevent the occurrence of sudden cardiac events," said Etienne Grima.

"CardioComm Solutions continues to be a significant player in ECG Management Solutions," noted Mr. Simi Grosman, a member of CardioComm Solution's Board of Directors, "under the stewardship of Dr. Anatoly Langer, the company's Chairman of the Board, and CEO Etienne Grima's business leadership and vision, the company is beginning to see the results of the last 3 years of continuous product development and software enhancements."

About CardioComm Solutions

CardioComm Solution's patented and proprietary technology is used in products for recording, viewing, analyzing and storing electrocardiograms (ECGs) for diagnosis and management of cardiac patients. Products are sold worldwide through a combination of an external distribution network and a North American-based sales team. The company has earned the ISO 13485 certification, is HPB approved, HIPAA compliant, and has received FDA market clearance for its software devices. CardioComm Solutions, Inc. is headquartered in Toronto, Canada, with offices in Victoria, B.C.

Forward-looking statements

This release may contain certain forward-looking statements with respect to the financial condition, results of operations and business of CardioComm Solutions and certain of the plans and objectives of CardioComm Solutions with respect to these items. By their nature, forward-looking statements involve risk and uncertainty because they relate to events and depend on circumstances that will occur in the future and there are many factors that could cause actual results and developments to differ materially from those expressed or implied by these forward-looking statements.

Neither TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this release.

Contacts:
CardioComm Solutions, Inc.
Etienne Grima
Chief Executive Officer
1-877-977-9425
egrima@cardiocommsolutions.com
www.cardiocommsolutions.com

Source: CardioComm Solutions, Inc.

TORONTO, ONTARIO--(Marketwire - Feb. 10, 2012) - CardioComm Solutions, Inc. (CardioComm Solutions) (TSX VENTURE: EKG) completed a recent interview with the Wall Street Reporter and an upcoming Ad in USA Today mark the beginning of a Marketing Communications Campaign in support of the company' entry into the Health Market with their recently announced Food and Drug Administration (FDA) clear HeartCheck(TM) Pen Hand Held ECG targeted at consumers.

In his interview with the Wall Street Reporter Mr. Etienne Grima, CEO, discussed CardioComm Solution's current direction in the field of Telemedicine and provided insight into planned initiatives that the company will be launching over the next 24 months, initiatives building on proven and stable software products. The interview highlighted CardioComm Solutions as a software engineering company that is not dependent on others for software enhancements and innovations, a company emerging from three years of planning with an aim to close the gap in providing access for patients and consumers to qualified medical care.

Francois Paul Thibault, Canadian Designer and Sculpture of Yellow Knife, NWT, Canada said, "I believe CardioComm's technology will empower people with direct access to doctors and professional teams at breakneck wireless internet speeds. This will streamline our health system to where it should be and reach well beyond. CardioComm's new wireless propriety software and HeartCheckTM PEN technology will allow patients and individuals from all areas of the globe to save valuable time. What CardioComm will offer is the opportunity to save millions of dollars in medical travel services in regions like the NWT, the Yukon and Nunavut. Each year hundreds of people fly escorted to large centers for these types of test at an incredible cost to our Government and Health Care system. Investing in one of these PEN devices will save a world of uncertainties, alleviate sleepless nights and most importantly may save a multitude of lives. Finally the Star Trek Era is here."

CardioComm Solutions to Co Sponsor Publication for National Heart Health Month

In keeping with their commitment to patient education and awareness, CardioComm Solutions, Inc. will be co-sponsoring a major educational publication and campaign for National Heart Health Month. On February 23rd, 2012, Mediaplanet Publishing, Inc. will be releasing its 5th edition of "Cardiovascular Health" to be distributed in USA Today in key regional markets. The publication will stress the importance of open patient-doctor dialogue and will also address issues around Atrial Fibrillation. "We thought this would be a great opportunity to introduce the HeartCheckTM PEN to a consumer audience and discuss how innovative patient monitoring can help prevent the occurrence of sudden cardiac events," said Etienne Grima.

"CardioComm Solutions continues to be a significant player in ECG Management Solutions," noted Mr. Simi Grosman, a member of CardioComm Solution's Board of Directors, "under the stewardship of Dr. Anatoly Langer, the company's Chairman of the Board, and CEO Etienne Grima's business leadership and vision, the company is beginning to see the results of the last 3 years of continuous product development and software enhancements."

About CardioComm Solutions

CardioComm Solution's patented and proprietary technology is used in products for recording, viewing, analyzing and storing electrocardiograms (ECGs) for diagnosis and management of cardiac patients. Products are sold worldwide through a combination of an external distribution network and a North American-based sales team. The company has earned the ISO 13485 certification, is HPB approved, HIPAA compliant, and has received FDA market clearance for its software devices. CardioComm Solutions, Inc. is headquartered in Toronto, Canada, with offices in Victoria, B.C.

Forward-looking statements

This release may contain certain forward-looking statements with respect to the financial condition, results of operations and business of CardioComm Solutions and certain of the plans and objectives of CardioComm Solutions with respect to these items. By their nature, forward-looking statements involve risk and uncertainty because they relate to events and depend on circumstances that will occur in the future and there are many factors that could cause actual results and developments to differ materially from those expressed or implied by these forward-looking statements.

Neither TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this release.

FOR FURTHER INFORMATION PLEASE CONTACT:
        CardioComm Solutions, Inc.
        Etienne Grima
        Chief Executive Officer
        1-877-977-9425
        egrima@cardiocommsolutions.com
        www.cardiocommsolutions.com

Source: CardioComm Solutions, Inc.